Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|February 18, 2019
Design, synthesis and biological evaluation of low molecular weight CXCR4 ligandsMaxwell M Sakyiamah, Takuya Kobayakawa, Masayuki Fujino, et al.
Bioconjugate Chemistry|July 4, 2017
Synthesis and Evaluation of Dimeric Derivatives of Diacylglycerol-Lactones as Protein Kinase C LigandsNami Ohashi, Ryosuke Kobayashi, Wataru Nomura, et al.
RSC Advances|March 23, 2023
Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2Kohei Tsuji, Kofi Baffour-Awuah Owusu, Yutaro Miura, et al.
European Journal of Medicinal Chemistry|May 24, 2023
Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activityTakahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.
Biochemical and Biophysical Research Communications|December 17, 2022
4-phenylquinoline-8-amine induces HIV-1 reactivation and apoptosis in latently HIV-1 infected cellsHaruki Kitamura, Sayaka Sukegawa, Kouki Matsuda, et al.
Bioorganic & Medicinal Chemistry|January 22, 2022
Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitorsKohei Tsuji, Takuya Kobayakawa, Kiju Konno, et al.
Chemmedchem|October 23, 2012
Low-molecular-weight CXCR4 ligands with variable spacersTetsuo Narumi, Haruo Aikawa, Tomohiro Tanaka, et al.
The Journal of Biological Chemistry|November 11, 2018
Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversalKouki Matsuda, Takuya Kobayakawa, Kiyoto Tsuchiya, et al.
Biomolecules|February 6, 2021
Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid ProteinsTakuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
ACS Infectious Diseases|May 21, 2024
Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing AgentsTakahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.
Pageof 5